Scientists have found a new way to study serious mental health conditions by growing very small human brains in the lab.
These tiny brains are about the size of a pea, but they may help doctors better understand schizophrenia and bipolar disorder.
These two conditions affect millions of people around the world, yet they are still very difficult to diagnose with clear medical tests.
Unlike some other brain diseases, schizophrenia and bipolar disorder do not have simple biological markers that doctors can measure. For example, Parkinson’s disease is linked to low levels of dopamine, a chemical in the brain.
Doctors can test for such changes. However, with schizophrenia and bipolar disorder, doctors mostly rely on observing behavior and listening to patients describe their symptoms. This process can take a long time, and sometimes it is hard to tell the difference between the two conditions.
In this new study, researchers at Johns Hopkins University used stem cell technology to grow small brain-like structures called brain organoids. Stem cells are special cells that can develop into many different types of cells in the body.
The scientists took skin and blood samples from people with schizophrenia, people with bipolar disorder, and people without mental illness. They then turned these samples into stem cells and guided them to grow into tiny brain organoids in the lab.
These mini-brains are not complete human brains, and they cannot think or feel. However, they contain several important types of brain cells, especially those found in the prefrontal cortex.
The prefrontal cortex is the part of the brain that helps with complex thinking, planning, and decision-making. The organoids also developed myelin, which is a protective covering that helps electrical signals move quickly between brain cells.
To understand how these mini-brains functioned, the researchers placed them on special microchips that contain tiny electrodes. These electrodes work like a very small EEG machine.
They record electrical signals from brain cells in real time. Brain cells communicate by sending electrical signals to each other, and the pattern of these signals shows how well brain networks are working.
When the team studied the electrical activity of the organoids, they noticed clear differences between those grown from healthy individuals and those grown from people with schizophrenia or bipolar disorder.
The neurons, which are the main signaling cells in the brain, fired in different patterns depending on the condition. These patterns acted like unique fingerprints for each disorder.
The researchers used machine learning, which is a type of computer system that can find patterns in large amounts of data. The computer analyzed the electrical firing patterns and tried to identify which organoid came from which patient group.
At first, the system correctly identified the source of the mini-brain with up to 83 percent accuracy. After the scientists applied gentle electrical stimulation to encourage more brain activity, the accuracy increased to 92 percent.
This finding is important because it suggests that schizophrenia and bipolar disorder may have distinct electrical signatures in the brain. These signatures are called electrophysiology signatures, which simply means patterns of electrical activity. If these patterns can be confirmed in larger studies, they may help doctors develop more objective tests in the future.
Another possible benefit of this research is improving treatment. Right now, doctors often use a trial-and-error approach to find the right medication for patients. This process can take months or even years. Some patients do not respond well to common medicines, including drugs such as clozapine.
If doctors could test different medications directly on a patient’s own lab-grown mini-brain, they might be able to see which drug works best before giving it to the patient. This could reduce suffering and shorten the time it takes to find effective treatment.
The study included samples from 12 patients, so more research is needed to confirm the results. The team is now working with other medical experts to collect more samples and to study how different drug doses affect the brain organoids.
If future studies support these findings, this approach could become a powerful new tool for diagnosing and treating mental health conditions more accurately and more quickly.
The research was published in the journal APL Bioengineering. The scientists hope that their work will open new doors in mental health care and bring more precise and personalized treatment options to patients in the future.
If you care about mental health, please read studies about how dairy foods may influence depression risk, and 6 foods you can eat to improve mental health.
For more mental health information, please see recent studies about top foods to tame your stress, and Omega-3 fats may help reduce depression.
Copyright © 2026 Knowridge Science Report. All rights reserved.
